Banner
Late-Breaking Analysis In Hypertension Shows That Antihypertensive Treatments Differ In Their Ability To Preserve Lives

STOCKHOLM, August 30, 2010 /PRNewswire/ -- According to the results of a late-breaking analysis...

Clinical Results For New Treatment Of Bacterial Vaginosis Infection

The Swedish company Laccure AB recently got CE marking as a Class IIa medical device product for...

88 Percent Of UK Doctors Believe Whiplash Claims Are Exaggerated

AXA, a UK car insurer, has surveyed UK doctors as part of its ongoing campaign to understand the...

On Facebook, Women Are More Plentiful But Men Are Better Ad Targets

Global digital marketing companies Resolution Media and Kenshoo Social published a new report today...

User picture.
Anna OhldenRSS Feed of this column.

Media Relations Executive, PR Newswire Europe... Read More »

Blogroll

LONDON, December 11 /PRNewswire/ --

- There's 15,000 Holiday Euros for the European Quitter!

The search is on for the first European Smoke Free Quitter of the Year 2008 who will be awarded the title and holiday vouchers worth 15,000 Euros. Eleven countries are participating including the UK and they will all choose a representative who will win a trip to the Award ceremony in Amsterdam in September 2008. You can also nominate a health care professional that has helped smokers quit and a public figure that has made an impact on smoking policy. To enter or nominate apply on line at http://www.quit.org.uk or ring Quitline 0800 002200

CALGARY, Canada, December 11 /PRNewswire/ -- Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) ("Oncolytics") today announced that it has been granted U.S. Patent 7,306,902 entitled "Oncolytic Viruses as Phenotyping Agents for Neoplasms." The claims describe methods of diagnosing cancers with unknown phenotypes by using oncolytic viruses that selectively replicate in cancer cells with known phenotypes.

"Oncolytic viruses are selective for certain mutations in cancer cells," said Dr. Matt Coffey, Chief Scientific Officer of Oncolytics. "By using these viruses in tumour samples, we may be able to more accurately diagnose the various cancer phenotypes, ultimately leading to a more individualized approach to cancer treatment."

About Oncolytics Biotech Inc.

CHICAGO, December 11 /PRNewswire/ --

- BREW Operator Creates India's First Full Mobile Internet Service

Novarra, the leader in mobile web gateway platforms and services, today announced that its Vision(TM) platform is powering Tata Indicom's market-leading full mobile internet service. The service is available on popular mass-market handsets such as the Motorola RAZR and the Samsung Explore.

BEIJING, December 11 /PRNewswire/ --

Peabody Energy (NYSE: BTU) today became the only non-Chinese equity partner in "GreenGen," the first near-zero emissions coal-fueled power plant with carbon capture and storage which is under development in China. Peabody joined the initiative at a formal signing ceremony at the prestigious State Guest House in Beijing. The agreement was announced during the Sino-U.S. Joint Commission on Commerce and Trade meetings attended by U.S. and Chinese dignitaries, including U.S. Secretary of the Treasury Henry M. Paulson, Jr. and China's Vice Premier Wu Yi.

HERTEN, Germany, December 11 /PRNewswire/ -- A considerable reduction in carbon dioxide in the world's industrial and emerging economies is vital if global warming is to be counteracted. The problem can be solved by energy savings on the one hand and energy efficiency on the other. The German corporation Aqua Society has now developed a process which sustainably generates CO2-free electricity from waste heat at temperatures from 80 degrees Celsius, making a decisive contribution to achieving climate targets.

Electricity Without Carbon Dioxide From Low-Temperature Heat

DALLAS, December 11 /PRNewswire/ --

- Kingdom sought trusted vendor for national ID project, e-government rollout to protect 27 million citizens